Evaluation of the Clinical and Anti-Destructive Effect of an Anti-B Cell Preparation Depending on Concomitant Therapy With Basic Anti-Inflammatory Drugs and Glucocorticoids in Patients With Rheumatoid Arthritis

Medical Council
doi 10.21518/2079-701x-2019-18-110-117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.

Related search

Anti-Inflammatory Drugs for Rheumatoid Arthritis

BMJ
1976English

Planning of a Clinical Data Registry for Basic Anti-Inflammatory Drugs for the Treatment of Rheumatoid Arthritis

The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
2018English

Differences in Safety of Non-Steroidal Anti-Inflammatory Drugs in Patients With Osteoarthritis and Rheumatoid Arthritis: A Randomized Clinical Trial

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Infections in Patients With Rheumatoid Arthritis Receiving Anti-Cytokine Therapy: Biological Mechanisms and Clinical Aspects

Reumatismo
Rheumatology
2011English

Economic Evaluation of Gastric Ulcer Prophylaxis in Patients With Arthritis Receiving Non-Steroidal Anti-Inflammatory Drugs.

Postgraduate Medical Journal
Medicine
1990English

Relationship Between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients With Rheumatoid Arthritis

International Journal of Medical Sciences
Medicine
2011English

Role of Anti-Inflammatory and Immunomodulatory Agents in Rheumatoid Arthritis.

Al-Azhar Journal of Pharmaceutical Sciences
2017English

Anti-B Cell Therapy in Patients With Systemic Lupus Erythematosus

Modern Rheumatology Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy